can you change from tirzepatide to semaglutide Switching Tirzepatide: Is It a Good Idea? Tirzepatide Vs. Semaglutide: Which Is

While retatrutide and SAR441255 demonstrate significant potential, several important aspects must be addressed to fully optimize the clinical application of triple agonists

Association between GLP-1 receptor agonist use and epilepsy risk in type 2 diabetes

FDA declared the semaglutide shortage resolved in February 2025, restricting compounded semaglutide to roughly 41 states

Nicholls SJ, Bhatt DL, Buse JB et al (2023) Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics